MERKEL, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 18.383
EU - Europa 2.348
AS - Asia 2.175
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 5
OC - Oceania 5
Totale 22.922
Nazione #
US - Stati Uniti d'America 18.362
CN - Cina 1.032
SG - Singapore 852
FI - Finlandia 545
IT - Italia 408
DE - Germania 353
SE - Svezia 308
FR - Francia 259
UA - Ucraina 235
VN - Vietnam 183
GB - Regno Unito 137
IE - Irlanda 41
IN - India 34
TR - Turchia 34
CA - Canada 20
GR - Grecia 19
HK - Hong Kong 17
NL - Olanda 9
RU - Federazione Russa 9
RO - Romania 8
EU - Europa 6
BG - Bulgaria 5
TH - Thailandia 5
JP - Giappone 4
MY - Malesia 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
SI - Slovenia 3
CH - Svizzera 2
CI - Costa d'Avorio 2
DK - Danimarca 2
EG - Egitto 2
PT - Portogallo 2
AT - Austria 1
AU - Australia 1
BN - Brunei Darussalam 1
CZ - Repubblica Ceca 1
IR - Iran 1
JO - Giordania 1
KR - Corea 1
LY - Libia 1
MX - Messico 1
NO - Norvegia 1
PH - Filippine 1
TW - Taiwan 1
Totale 22.922
Città #
Fairfield 2.610
Woodbridge 1.857
Houston 1.644
Ann Arbor 1.410
Chandler 1.343
Jacksonville 1.132
Ashburn 1.087
Wilmington 1.068
Seattle 937
Cambridge 889
Singapore 665
Boardman 537
Princeton 531
Santa Clara 405
Medford 287
San Diego 260
Nanjing 224
Dong Ket 180
Beijing 177
Des Moines 163
Helsinki 161
Roxbury 148
Guangzhou 90
Norwalk 75
Shenyang 73
Hebei 72
Padova 69
Nanchang 66
Changsha 57
Jiaxing 50
Dublin 40
Tianjin 32
Yenibosna 32
Munich 27
Redwood City 27
Rome 27
London 26
Kharkiv 25
New York 19
Jinan 18
Hong Kong 17
Dearborn 12
Ogden 12
Chicago 10
Kunming 10
Borås 9
Hounslow 9
Milan 9
Zhengzhou 9
Falls Church 8
Dallas 7
Genoa 7
Venice 7
Bologna 6
Hangzhou 6
Kilburn 6
Ningbo 6
Ottawa 6
Rockville 6
Taizhou 6
Varese 6
Bari 5
Cesa 5
Florence 5
Lanzhou 5
Los Angeles 5
Mestre 5
Nove 5
Pune 5
Shanghai 5
Sofia 5
Trento 5
Washington 5
Auburn Hills 4
Catania 4
Chengdu 4
Indiana 4
Islington 4
Kuala Lumpur 4
Palermo 4
Paris 4
Pescara 4
Reggio Emilia 4
Sirmione 4
Southwark 4
Taiyuan 4
Toronto 4
Atena Lucana 3
Brindisi 3
Buffalo 3
Chiswick 3
Cornate D'adda 3
Detroit 3
Frankfurt Am Main 3
Fuzhou 3
Islamabad 3
Las Vegas 3
North York 3
Prescot 3
Sarmede 3
Totale 18.869
Nome #
The animal naming test: An easy tool for the assessment of hepatic encephalopathy 194
Increased myoendothelial gap junctions mediate the enhanced response to epoxyeicosatrienoic acid and acetylcholine in mesenteric arterial vessels of cirrhotic rats. 151
The self-morningness/eveningness (Self-ME): An extremely concise and totally subjective assessment of diurnal preference 143
A SIMPLIFIED PSYCHOMETRIC EVALUATION FOR THE DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHY 139
Interobserver and inter-equipment variability of echo-Doppler sonographic evaluation of the superior mesenteric artery. 138
Acute liver rejection: Accuracy and predictive values of Doppler US measurements - Initial experience 133
Nutrition and survival in patients with liver cirrhosis 127
A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis 126
Clinical value of asterixis in 374 well-characterised patients with cirrhosis and varying degree of hepatic encephalopathy 126
Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as guidance for prophylaxis and treatment of bleeding and re-bleeding? Yes! 121
Ammonia-related changes in cerebral electrogenesis in healthy subjects and patients with cirrhosis. 121
Blood flow of experimental liver metastases in rat as evaluated by the locally injected 133-Xenon washout. 120
Effect of somatostatin on liver blood flow and liver metabolic activity in patients with cirrhosis. 119
New abdominal collaterals at ultrasound: A clue of progression of portal hypertension 119
Training of Italian emergency medicine residents in prehospital emergency medicine:state of the art and perspectives of improvement 119
Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. 118
Change in portal flow after liver transplantation: effect on hepatic arterial resistance indices and role of spleen size 118
Haeme oxygenase mediates hyporeactivity to phenylephrine in the mesenteric vessels of cirrhotic rats with ascites 116
Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria 115
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 115
EVALUATION OF SPLANCHNIC ANGIOGRAPHY AS A PROGNOSTIC INDEX OF SURVIVAL IN PATIENTS WITH CIRRHOSIS 114
Electroencephalography in patients with cirrhosis. 114
Beta-blockers in the prevention of aggravation of esophageal varices in patients with cirrhosis and small varices: a placebo-controlled clinical trial. 114
Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension 110
Different hemodynamic patterns of alcoholic and viral endstage cirrhosis: analysis of explanted liver weight, degree of fibrosis and splanchnic Doppler parameters 110
Incidence and natural history of small esophageal varices in cirrhotic patients 108
Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats 107
A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis 106
Renal water and sodium handling in compensated liver cirrhosis: mechanism of the impaired natriuresis after saline loading. 106
Encephalopathy or hepatic encephalopathy? 105
Hepatitis C virus reinfection in liver transplant patients: evaluation of liver damage progression with echo-color doppler. 105
Renal effects of nadolol in cirrhosis. 103
The Influence of Environmental Factors on Sleep Quality in Hospitalized Medical Patients 103
Hepatitis C Virus Reinfection in Liver Transplant Patients: Evaluation of Liver Damage Progression with Echo-Color Doppler 103
Accuracy and predictive value of echo-Doppler measurements in acute liver rejection -- initial experience 101
Effects of chronic therapy with nadolol on portal hemodynamics and on splanchnic impedance indices using Doppler sonography: Comparison between acute and chronic effects 101
Visual attention in cirrhotic patients: a study on covert visual attention orienting. 100
Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver disease 100
Il timing del trapianto di fegato: Child-Pugh o Mayo score? 99
Metabolic control of kidney hemodynamics in normal and insulin-dependent diabetic subjects. Effects of acetoacetic, lactic, and acetic acids. 99
A short cut to predict the clinical response to beta-blocker therapy in cirrhosis? 98
Renal haemodynamics in essential hypertension assessed by 133-Xenon washout and selective renal angiography 98
Prognostic benefit of the addition of an electroencephalographic (EEG) index to the MELD score: the MELD-EEG. 97
Simple tools for complex syndromes: A three-level difficulty test for hepatic encephalopathy 97
Carbon monoxide-mediated activation of a large-conductance calcium-activated potassium channels contrinutes to mesenteric vasodilation in cirrhotic rats. 321 : 187-194. 96
Nadolol for prevention of variceal rebleeding in cirrhosis: a controlled clinical trial. 96
Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow. 96
Cost-effectiveness analysis of beta-blockers vs endoscopic surveillance in patients with cirrhosis and small varices 96
Portal hypertension and portal hypertensive gastropathy in patients with liver cirrhosis: a haemodynamic study 96
Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis. 95
Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension. 95
Prognostic Benefit of the Addition of a Quantitative Index of Hepatic Encephalopathy to the MELD score: the MELD-EEG 95
Long-term effects of beta-adrenergic blockade with nadolol on hepatic and renal haemodynamics and function in cirrhotics. 95
Interobserver and inter-equipment variability of echo-Doppler evaluation of the superior mesenteric artery. 94
Natural History of cirrhotic patients with small esophageal varices: a prospective study 93
Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats with ascites 93
Theophylline pharmacokinetics and liver function indexes in chronic liver disease. 92
Heme oxygenase regulates the response of intrarenal arteries to alpha-adrenergic stimulation in experimental cirrhosis. 92
Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension 91
Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost 91
Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. 91
Confounders in the detection of minimal hepatic encephalopathy: a neuropsychological and quantified EEG study. 91
AISF practice guidelines for portal hypertension.Committee for portal hypertension of the Italian Association for the Study of the Liver. 89
Porcine and human insulin absorption from subcutaneous tissues in normal and insulin dependent diabetic subjects: a deconvolution-based approach 89
Sleep-wake abnormalities in patients with cirrhosis. 89
HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients 89
Attention: Minimal hepatic encephalopathy and road accidents 88
PLASMA CARNITINE LEVELS IN LIVER-CIRRHOSIS - RELATIONSHIP WITH NUTRITIONAL-STATUS AND LIVER-DAMAGE 87
Bright times for patients with cirrhosis and delayed sleep habits: a case report of the beneficial effect of light therapy 87
Hemodynamic and clinical evaluation of nadolol in the treatment of portal hypertension in patients with cirrhosis. 87
Optimizing the time-frame for the definition of bleeding-related death after acute variceal bleeding in cirrhosis 86
Updating prognosis of cirrhosis by Cox's regression model using Child-Pugh score and aminopyrine breath test as time-dependent covariates 86
Endotoxins and the hepatorenal syndrome. 86
Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis 85
The use of human albumin millimicrospheres tagged with 99mTc in the evaluation of the removal capacity of the reticuloendothelial system. 85
IgM-linked SerpinB3 and SerpinB4 in Sera of Patients with Chronic Liver Disease 85
Intrarenal blood flow, circulation time, and cortical vascular volume in patients with cirrhosis. 85
Validation of a predictive model for chronic renal dysfunction following liver transplantation. 85
Value of prealbumin plasma levels as liver test. 84
A COST-EFFECTIVENESS ANALYSIS OF PROPHYLAXIS OF VARICEAL BLEEDING STARTING FROM SMALL ESOPHAGEAL VARICES COMPARED TO SURVEILLANCE AND TREATMENT STARTING FROM LARGE ONES 84
The cirrhotic patient with no varices and with small varices 84
Clinical significance of the evaluation of hepatic reticuloendothelial removal capacity in patients with cirrhosis. 84
Lowering portal pressure improves outcomes of patients with cirrhosis, with or without ascites: a meta-analysis. 84
Short-term effects of transcatheter arterial chemoembolisation on metabolic activity of the liver of cirrhotic patients with hepatocellular carcinoma 84
Vascularization of experimental liver metastases. 2 - Blood flow. 83
Prognostic indicators of risk for first variceal bleeding in cirrhosis: A multicenter study in 711 patients to validate and improve the North Italian Endoscopic Club (NIEC) Index 83
Malnutrition in alcoholic and virus-related cirrhosis 82
Hypotensive and renal effects of captopril. 82
Effect of nadolol on liver haemodynamics and function in patients with cirrhosis. 82
Prevention of the formation and growth of esophageal varices 81
The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis 81
Splenic Doppler impedance indices: influence of different portal hemodynamic conditions. 81
Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. 81
Cirrhosis and muscle cramps: evidence of a causal relationship. 80
Covert hepatic encephalopathy: Agreement and predictive validity of different indices 80
PGE2 urinary escretion and renal haemodynamics after nadolol treatment of portal hypertension in patients with liver cirrhosis. 79
Primary Prophylaxis of Bleeding from Esophageal Varices in Cirrhosis 79
Endoscopic screening for esophageal varices in cirrhotic patients 78
Nutritional and prognostic significance of serum hypothyroxinemia in hospitalized patients with liver cirrhosis 78
Evaluation of renal tubular damage in liver cirrhosis by urinary enzymes and beta-2-microglobulin excretions. 78
Totale 9.944
Categoria #
all - tutte 82.342
article - articoli 64.896
book - libri 706
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.332
Totale 152.276


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.309 0 0 0 0 0 0 388 509 493 406 279 234
2020/20212.593 123 212 60 195 103 255 71 272 394 253 319 336
2021/20223.553 56 577 371 212 188 169 135 354 207 52 346 886
2022/20232.937 699 244 79 281 495 436 3 186 344 18 112 40
2023/20241.093 63 205 102 85 58 58 33 33 45 23 191 197
2024/20252.210 9 481 323 261 1.009 118 9 0 0 0 0 0
Totale 23.000